Paragon 28 announces expiration of HSR waiting period for pending acquisition
Written by Emily J. Thompson, Senior Investment Analyst
Acquisition Update: Paragon 2 (FNA) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act has expired regarding the acquisition of Paragon 28 by Zimmer Biomet Holdings (ZBH).
Regulatory Approval: The expiration indicates that regulatory approval processes related to the acquisition are progressing as planned.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
